The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Benefit from CMF with or without anthracyclines in relation to biologic profiles in early breast cancer.
A. Rocca
No relevant relationships to disclose
A. Paradiso
No relevant relationships to disclose
P. Sismondi
No relevant relationships to disclose
E. Scarpi
No relevant relationships to disclose
A. Mangia
No relevant relationships to disclose
L. Medri
No relevant relationships to disclose
S. Bravaccini
No relevant relationships to disclose
D. Casadei Giunchi
No relevant relationships to disclose
D. Amadori
No relevant relationships to disclose
R. Silvestrini
No relevant relationships to disclose